Neurology and Neurosurgery - Global Neurology Academy

81-96 of 455

Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
NeuroFrontiers
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
NeuroFrontiers
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
- David Gate, PhD
Understanding MS: Managing Hidden and Overlooked Symptoms
Understanding MS: Managing Hidden and Overlooked Symptoms
Global Neurology Academy
Understanding MS: Managing Hidden and Overlooked Symptoms
- Marisa McGinley, DO
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
NeuroFrontiers
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
- Marisa McGinley, DO
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
NeuroFrontiers
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
- Marisa McGinley, DO
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiers
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiers
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
NeuroFrontiers
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
NeuroFrontiers
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
NeuroFrontiers
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
NeuroFrontiers
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
Rethinking Migraine Care: Prioritizing Patient Needs and Restoring Function
Rethinking Migraine Care: Prioritizing Patient Needs and Restoring Function
On the Frontlines of Migraine
Rethinking Migraine Care: Prioritizing Patient Needs and Restoring Function
- Ashley Baker, MSN, PMHNP
- Stephanie Nahas, MD, MSEd
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
On the Frontlines of Migraine
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
- Ryan Quigley
- Lyn R. Griffiths
Challenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
Challenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
On the Frontlines of Migraine
Challenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
- Charles Turck, PharmD, BCPS, BCCCP
- Rashmi B. Halker Singh, M.D.
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
NeuroFrontiers
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
NeuroFrontiers
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS

Previous
1
2
…
4
5
6
7
8
…
28
29
Next

6/11